AbbVie Inc. closed $6.48 below its 52-week high ($199.95), which the company reached on September 3rd.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...

The stock's fall snapped a two-day winning streak.

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the ...

Daniel Reiner, an investor in companies worth billions of dollars, was found dead in a Pend Oreille County lake he owned with ...

The global anxiety disorders and depression treatment market, valued at approximately USD 11.2 billion in 2021, is on track ...

With the help of the Spokane County dive team, the body of the 72-year-old Reiner was recovered from the roughly 95-acre lake ...

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

The stock of eyecare company Bausch + Lomb Corp. was up 14%on Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its indebted ...

DBS analyst Mark Kong CFA has maintained their neutral stance on ABBV stock, giving a Hold rating on September 3. Mark Kong CFA has given his ...